These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1572 related articles for article (PubMed ID: 30025570)
1. Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry. Greene SJ; Butler J; Albert NM; DeVore AD; Sharma PP; Duffy CI; Hill CL; McCague K; Mi X; Patterson JH; Spertus JA; Thomas L; Williams FB; Hernandez AF; Fonarow GC J Am Coll Cardiol; 2018 Jul; 72(4):351-366. PubMed ID: 30025570 [TBL] [Abstract][Full Text] [Related]
2. Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction. Greene SJ; Fonarow GC; DeVore AD; Sharma PP; Vaduganathan M; Albert NM; Duffy CI; Hill CL; McCague K; Patterson JH; Spertus JA; Thomas L; Williams FB; Hernandez AF; Butler J J Am Coll Cardiol; 2019 May; 73(19):2365-2383. PubMed ID: 30844480 [TBL] [Abstract][Full Text] [Related]
3. Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities. Albert NM; Tyson RJ; Hill CL; DeVore AD; Spertus JA; Duffy C; Butler J; Patterson JH; Hernandez AF; Williams FB; Thomas L; Fonarow GC Am Heart J; 2021 May; 235():82-96. PubMed ID: 33497697 [TBL] [Abstract][Full Text] [Related]
4. Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry. Greene SJ; Butler J; Hellkamp AS; Spertus JA; Vaduganathan M; Devore AD; Albert NM; Patterson JH; Thomas L; Williams FB; Hernandez AF; Fonarow GC J Card Fail; 2022 Mar; 28(3):370-384. PubMed ID: 34793971 [TBL] [Abstract][Full Text] [Related]
5. Medical Therapy During Hospitalization for Heart Failure With Reduced Ejection Fraction: The VICTORIA Registry. Greene SJ; Ezekowitz JA; Anstrom KJ; Demyanenko V; Givertz MM; Piña IL; O'Connor CM; Koglin J; Roessig L; Hernandez AF; Armstrong PW; Mentz RJ J Card Fail; 2022 Jul; 28(7):1063-1077. PubMed ID: 35301107 [TBL] [Abstract][Full Text] [Related]
6. Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry. Peri-Okonny PA; Mi X; Khariton Y; Patel KK; Thomas L; Fonarow GC; Sharma PP; Duffy CI; Albert NM; Butler J; Hernandez AF; McCague K; Williams FB; DeVore AD; Patterson JH; Spertus JA JACC Heart Fail; 2019 Apr; 7(4):350-358. PubMed ID: 30738978 [TBL] [Abstract][Full Text] [Related]
7. Gap between guidelines and clinical practice in heart failure with reduced ejection fraction: Results from TSOC-HFrEF registry. Chang HY; Wang CC; Wei J; Chang CY; Chuang YC; Huang CL; Chong E; Lin JL; Mar GY; Chan KC; Kuo JY; Wang JH; Chen ZC; Tseng WK; Cherng WJ; Yin WH J Chin Med Assoc; 2017 Dec; 80(12):750-757. PubMed ID: 29033112 [TBL] [Abstract][Full Text] [Related]
8. Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF Registry. Vaduganathan M; Fonarow GC; Greene SJ; DeVore AD; Kavati A; Sikirica S; Albert NM; Duffy CI; Hill CL; Patterson JH; Spertus JA; Thomas LE; Williams FB; Hernandez AF; Butler J JACC Heart Fail; 2020 Jun; 8(6):469-480. PubMed ID: 32387066 [TBL] [Abstract][Full Text] [Related]
10. Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: An analysis from the HELP-HF registry. Tomasoni D; Pagnesi M; Colombo G; Chiarito M; Stolfo D; Baldetti L; Lombardi CM; Adamo M; Maggi G; Inciardi RM; Loiacono F; Maccallini M; Villaschi A; Gasparini G; Montella M; Contessi S; Cocianni D; Perotto M; Barone G; Merlo M; Cappelletti AM; Rosano G; Sinagra G; Pini D; Savarese G; Metra M Eur J Heart Fail; 2024 Feb; 26(2):327-337. PubMed ID: 37933210 [TBL] [Abstract][Full Text] [Related]
11. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry. Brunner-La Rocca HP; Linssen GC; Smeele FJ; van Drimmelen AA; Schaafsma HJ; Westendorp PH; Rademaker PC; van de Kamp HJ; Hoes AW; Brugts JJ; JACC Heart Fail; 2019 Jan; 7(1):13-21. PubMed ID: 30606482 [TBL] [Abstract][Full Text] [Related]
12. Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction. Butler J; Yang M; Manzi MA; Hess GP; Patel MJ; Rhodes T; Givertz MM J Am Coll Cardiol; 2019 Mar; 73(8):935-944. PubMed ID: 30819362 [TBL] [Abstract][Full Text] [Related]
13. Medical therapy doses at hospital discharge in patients with existing and de novo heart failure. Diamant MJ; Virani SA; MacKenzie WJ; Ignaszewski A; Toma M; Hawkins NM ESC Heart Fail; 2019 Aug; 6(4):774-783. PubMed ID: 31218850 [TBL] [Abstract][Full Text] [Related]
14. Heart failure medication dosage and survival in women and men seen at outpatient clinics. Bots SH; Onland-Moret NC; Tulevski II; van der Harst P; Cramer MJM; Asselbergs FW; Somsen GA; den Ruijter HM Heart; 2021 Nov; 107(21):1748-1755. PubMed ID: 34261736 [TBL] [Abstract][Full Text] [Related]
15. Modern heart failure treatment is superior to conventional treatment across the left ventricular ejection spectrum: real-life data from the Swedish Heart Failure Registry 2013-2020. Karlström P; Pivodic A; Dahlström U; Fu M Clin Res Cardiol; 2024 Sep; 113(9):1355-1368. PubMed ID: 39186181 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Usage and Dosing of Guideline-Directed Medical Therapy for Heart Failure With Reduced Ejection Fraction Patients in Clinical Practice. Smith KV; Dunning JR; Fischer CM; MacLean TE; Bosque-Hamilton JW; Fera LE; Grant JY; Zelle DJ; Matta L; Gaziano TA; MacRae CA; Scirica BM; Desai AS J Pharm Pract; 2022 Oct; 35(5):747-751. PubMed ID: 33813934 [TBL] [Abstract][Full Text] [Related]
17. Effect of heart failure pharmacotherapies in patients with heart failure with mildly reduced ejection fraction. Schupp T; Bertsch T; Reinhardt M; Abel N; Schmitt A; Lau F; Abumayyaleh M; Akin M; Weiß C; Weidner K; Behnes M; Akin I Eur J Prev Cardiol; 2024 Aug; 31(11):1347-1360. PubMed ID: 38513366 [TBL] [Abstract][Full Text] [Related]
18. Physician perceptions, attitudes, and strategies towards implementing guideline-directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice. Savarese G; Lindberg F; Christodorescu RM; Ferrini M; Kumler T; Toutoutzas K; Dattilo G; Bayes-Genis A; Moura B; Amir O; Petrie MC; Seferovic P; Chioncel O; Metra M; Coats AJS; Rosano GMC Eur J Heart Fail; 2024 Jun; 26(6):1408-1418. PubMed ID: 38515385 [TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center. Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333 [TBL] [Abstract][Full Text] [Related]
20. Impact of Individual Patient Profiles on Adherence to Guideline Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction: VCOR-HF Study. Driscoll A; Dinh D; Wong J; Hopper I; Mariani J; Zimmet H; Brennan A; Lefkovits J; Carruthers H; Reid CM Heart Lung Circ; 2020 Dec; 29(12):1782-1789. PubMed ID: 32646638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]